Replicate Bioscience, Inc.
San Diego, CA, US· latest recorded location
Replicate Bioscience, Inc. is named on 3 US grants and 11 published applications in this corpus. Its most frequent classification is C12N (Microorganisms or enzymes).
- Granted patents
- 3
- Published applications
- 11
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 16 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 3 |
| 2025 | 0 | 6 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 14 documents
- C12NMicroorganisms or enzymes14
- A61KMedicines and medical preparations13
- C07KPeptides12
- A61PTherapeutic uses of medicines9
- A01KAnimal husbandry4
- C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition2
- B82YSpecific uses or applications of nanostructures1
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1
- C12YEnzymes1
Recent patents
- Compositions and methods for expression of IL-12 and IL-1RA16 Jan 2024US 11,873,507 B2
- Compositions and methods for the prevention and treatment of rabies virus infection22 Aug 2023US 11,730,804 B1
- Compositions and methods for inducing ESR1, PI3K, HER2, and HER3 immune responses29 Nov 2022US 11,510,975 B1
- Modified madariaga viruses, self-replicating rna constructs, and uses thereof30 Jul 2026US 2026/0218170 A1
- Modified western equine encephalitis viruses and uses thereof14 Aug 2025US 2025/0257329 A1
- Compositions and methods for the prevention and treatment of rabies virus infection12 Jun 2025US 2025/0186574 A1
- Methods for generating functional self-replicating rna molecules8 May 2025US 2025/0146038 A1
- Compositions and methods for expression of il-12 and il-1ra23 Jan 2025US 2025/0027109 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.